Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review

HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies

(2014) C. A. Fernandez et al.   BLOOD

Comparison of Allergic Reactions to Intravenous and Intramuscular Pegaspargase in Children with Acute Lymphoblastic Leukemia

(2014) William C. Petersen et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Comparison of Hypersensitivity Reactions to PEG-Asparaginase in Children After Intravenous and Intramuscular Administration

(2013) Keith J. August et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse

(2011) Joanne Kurtzberg et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Asparaginase revisited

(2011) Henk van den Berg   LEUKEMIA & LYMPHOMA

Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly

(2011) Mahati Pidaparti et al.   PEDIATRIC BLOOD & CANCER

Positive skin test to pegylated drug in a patient with anaphylaxis to polyethylene glycol

(2011) L. Guilleminault et al.   Revue Francaise d Allergologie

Epidemiology and risk factors for drug allergy

(2010) Bernard Y-H. Thong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Peg-asparaginase for acute lymphoblastic leukemia

(2010) Michael Rytting   EXPERT OPINION ON BIOLOGICAL THERAPY

Silent hypersensitivity toEscherichia coliasparaginase in children with acute lymphoblastic leukemia

(2010) Marion Strullu et al.   LEUKEMIA & LYMPHOMA

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

(2009) L. B. Silverman et al.   BLOOD